Skip to main content
Top
Published in: Cancer Causes & Control 3/2017

01-03-2017 | Original paper

Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study

Authors: Maria C. Katapodi, Deb Duquette, James J. Yang, Kari Mendelsohn-Victor, Beth Anderson, Christos Nikolaidis, Emily Mancewicz, Laurel L. Northouse, Sonia Duffy, David Ronis, Kara J. Milliron, Nicole Probst-Herbst, Sofia D. Merajver, Nancy K. Janz, Glenn Copeland, Scott Roberts

Published in: Cancer Causes & Control | Issue 3/2017

Login to get access

Abstract

Purpose

Cancer genetic services (counseling/testing) are recommended for women diagnosed with breast cancer younger than 45 years old (young breast cancer survivors—YBCS) and at-risk relatives. We present recruitment of YBCS, identification and recruitment of at-risk relatives, and YBCS willingness to contact their cancer-free, female relatives.

Methods

A random sample of 3,000 YBCS, stratified by race (Black vs. White/Other), was identified through a population-based cancer registry and recruited in a randomized trial designed to increase use of cancer genetic services. Baseline demographic, clinical, and family characteristics, and variables associated with the Theory of Planned Behavior (TPB) were assessed as predictors of YBCS’ willingness to contact at-risk relatives.

Results

The 883 YBCS (33.2% response rate; 40% Black) who returned a survey had 1,875 at-risk relatives and were willing to contact 1,360 (72.5%). From 853 invited at-risk relatives (up to two relatives per YBCS), 442 responded (51.6% response rate). YBCS with larger families, with a previous diagnosis of depression, and motivated to comply with recommendations from family members were likely to contact a greater number of relatives. Black YBCS were more likely to contact younger relatives and those living further than 50 miles compared to White/Other YBCS.

Conclusion

It is feasible to recruit diverse families at risk for hereditary cancer from a population-based cancer registry. This recruitment approach can be used as a paradigm for harmonizing processes and increasing internal and external validity of large-scale public health genomic initiatives in the era of precision medicine.
Literature
1.
go back to reference Bowen MS, Kolor K, Dotson WD, Ned RM, Khoury MJ (2012) Public health action in genomics is now needed beyond newborn screening. Public Health Genom 15(6):327–334. doi:10.1159/000341889 CrossRef Bowen MS, Kolor K, Dotson WD, Ned RM, Khoury MJ (2012) Public health action in genomics is now needed beyond newborn screening. Public Health Genom 15(6):327–334. doi:10.​1159/​000341889 CrossRef
4.
go back to reference Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 160(4):255–266. doi:10.7326/M13-1684 CrossRefPubMed Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 160(4):255–266. doi:10.​7326/​M13-1684 CrossRefPubMed
7.
go back to reference Pal T, Rocchio E, Garcia A, Rivers D, Vadaparampil S (2011) Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach. Genet Test Mol Biomarkers 15(1–2):69–77. doi:10.1089/gtmb.2010.0098 CrossRef Pal T, Rocchio E, Garcia A, Rivers D, Vadaparampil S (2011) Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach. Genet Test Mol Biomarkers 15(1–2):69–77. doi:10.​1089/​gtmb.​2010.​0098 CrossRef
8.
go back to reference Simmons RG, Lee YC, Stroup AM, Edwards SL, Rogers A, Johnson C, Wiggins CL, Hill DA, Cress RD, Lowery J, Walters ST, Jasperson K, Higginbotham JC, Williams MS, Burt RW, Schwartz MD, Kinney AY (2013) Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial. Trials 14:116. doi:10.1186/1745-6215-14-116 CrossRefPubMedPubMedCentral Simmons RG, Lee YC, Stroup AM, Edwards SL, Rogers A, Johnson C, Wiggins CL, Hill DA, Cress RD, Lowery J, Walters ST, Jasperson K, Higginbotham JC, Williams MS, Burt RW, Schwartz MD, Kinney AY (2013) Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial. Trials 14:116. doi:10.​1186/​1745-6215-14-116 CrossRefPubMedPubMedCentral
9.
go back to reference Smith T, Stein KD, Mehta CC, Kaw C, Kepner JL, Buskirk T, Stafford J, Baker F (2007) The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer 109(1):1–12. doi:10.1002/cncr.22387 CrossRefPubMed Smith T, Stein KD, Mehta CC, Kaw C, Kepner JL, Buskirk T, Stafford J, Baker F (2007) The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer 109(1):1–12. doi:10.​1002/​cncr.​22387 CrossRefPubMed
10.
go back to reference Courtney RJ, Paul CL, Carey ML, Sanson-Fisher RW, Macrae FA, D’Este C, Hill D, Barker D, Simmons J (2013) A population-based cross-sectional study of colorectal cancer screening practices of first- degree relatives of colorectal cancer patients. BMC Cancer 13(1):13CrossRefPubMedPubMedCentral Courtney RJ, Paul CL, Carey ML, Sanson-Fisher RW, Macrae FA, D’Este C, Hill D, Barker D, Simmons J (2013) A population-based cross-sectional study of colorectal cancer screening practices of first- degree relatives of colorectal cancer patients. BMC Cancer 13(1):13CrossRefPubMedPubMedCentral
11.
go back to reference Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 95(6):448–457CrossRefPubMed Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 95(6):448–457CrossRefPubMed
12.
go back to reference Lijovic M, Davis SR, Fradkin P, La China M, Farrugia H, Wolfe R, Bell RJ (2008) Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC Cancer 8:126. doi:10.1186/1471-2407-8-126 CrossRefPubMedPubMedCentral Lijovic M, Davis SR, Fradkin P, La China M, Farrugia H, Wolfe R, Bell RJ (2008) Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC Cancer 8:126. doi:10.​1186/​1471-2407-8-126 CrossRefPubMedPubMedCentral
13.
go back to reference Sutherland HJ, Lacroix J, Knight J, Andrulis IL, Boyd NF, Ontario Cancer Genetics, N (2001) The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario. J Clin Epidemiol 54(1):93–98CrossRefPubMed Sutherland HJ, Lacroix J, Knight J, Andrulis IL, Boyd NF, Ontario Cancer Genetics, N (2001) The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario. J Clin Epidemiol 54(1):93–98CrossRefPubMed
14.
go back to reference Carpentier MY, Tiro JA, Savas LS, Bartholomew LK, Melhado TV, Coan SP, Argenbright KE, Vernon SW (2013) Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv 7(1):155–163. doi:10.1007/s11764-012-0259-1 CrossRefPubMed Carpentier MY, Tiro JA, Savas LS, Bartholomew LK, Melhado TV, Coan SP, Argenbright KE, Vernon SW (2013) Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv 7(1):155–163. doi:10.​1007/​s11764-012-0259-1 CrossRefPubMed
15.
go back to reference Pakilit AT, Kahn BA, Petersen L, Abraham LS, Greendale GA, Ganz PA (2001) Making effective use of tumor registries for cancer survivorship research. Cancer 92(5):1305–1314CrossRefPubMed Pakilit AT, Kahn BA, Petersen L, Abraham LS, Greendale GA, Ganz PA (2001) Making effective use of tumor registries for cancer survivorship research. Cancer 92(5):1305–1314CrossRefPubMed
16.
go back to reference Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D, Colon Cancer Family R (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16(11):2331–2343. doi:10.1158/1055-9965.EPI-07-0648 CrossRefPubMed Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D, Colon Cancer Family R (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16(11):2331–2343. doi:10.​1158/​1055-9965.​EPI-07-0648 CrossRefPubMed
17.
go back to reference Carey M, Sanson-Fisher R, Macrae F, Hill D, D’Este C, Paul C, Doran C (2012) Improving adherence to surveillance and screening recommendations for people with colorectal cancer and their first degree relatives: a randomized controlled trial. BMC Cancer 12. doi:10.1186/1471-2407-12-62, Artn 62 Carey M, Sanson-Fisher R, Macrae F, Hill D, D’Este C, Paul C, Doran C (2012) Improving adherence to surveillance and screening recommendations for people with colorectal cancer and their first degree relatives: a randomized controlled trial. BMC Cancer 12. doi:10.​1186/​1471-2407-12-62, Artn 62
18.
go back to reference Anderson B, McLosky J, Wasilevich E, Lyon-Callo S, Duquette D, Copeland G (2012) Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. J Cancer Epidemiol 2012:298745. doi:10.1155/2012/298745 CrossRefPubMedPubMedCentral Anderson B, McLosky J, Wasilevich E, Lyon-Callo S, Duquette D, Copeland G (2012) Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. J Cancer Epidemiol 2012:298745. doi:10.​1155/​2012/​298745 CrossRefPubMedPubMedCentral
19.
go back to reference Knight JA, Sutherland HJ, Glendon G, Boyd NF, Andrulis IL, Network OCG (2002) Characteristics associated with participation at various stages at the Ontario site of the Cooperative Family Registry for Breast Cancer Studies. Ann Epidemiol 12(1):27–33. doi:Doi:10.1016/S1047-2797(01)00253-8 CrossRefPubMed Knight JA, Sutherland HJ, Glendon G, Boyd NF, Andrulis IL, Network OCG (2002) Characteristics associated with participation at various stages at the Ontario site of the Cooperative Family Registry for Breast Cancer Studies. Ann Epidemiol 12(1):27–33. doi:Doi:10.​1016/​S1047-2797(01)00253-8 CrossRefPubMed
20.
go back to reference Katapodi MC, Northouse LL, Schafenacker AM, Duquette D, Duffy SA, Ronis DL, Anderson B, Janz NK, McLosky J, Milliron KJ, Merajver SD, Duong LM, Copeland G (2013) Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening. BMC Cancer. 13. doi:10.1186/1471-2407-13-97, Artn 97 Katapodi MC, Northouse LL, Schafenacker AM, Duquette D, Duffy SA, Ronis DL, Anderson B, Janz NK, McLosky J, Milliron KJ, Merajver SD, Duong LM, Copeland G (2013) Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening. BMC Cancer. 13. doi:10.​1186/​1471-2407-13-97, Artn 97
23.
go back to reference Beskow LM, Millikan RC, Sandler RS, Godley PA, Weiner BJ, Weinberger M (2006) The effect of physician permission versus notification on research recruitment through cancer registries (United States). Cancer Causes Control 17(3):315–323. doi:10.1007/s10552-005-0521-1 CrossRefPubMed Beskow LM, Millikan RC, Sandler RS, Godley PA, Weiner BJ, Weinberger M (2006) The effect of physician permission versus notification on research recruitment through cancer registries (United States). Cancer Causes Control 17(3):315–323. doi:10.​1007/​s10552-005-0521-1 CrossRefPubMed
25.
go back to reference Katapodi MC, Northouse LL, Milliron KJ, Liu G, Merajver SD (2013) Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families. Psychooncology 22(6):1336–1343. doi:10.1002/pon.3139 CrossRefPubMed Katapodi MC, Northouse LL, Milliron KJ, Liu G, Merajver SD (2013) Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families. Psychooncology 22(6):1336–1343. doi:10.​1002/​pon.​3139 CrossRefPubMed
26.
go back to reference Su Y-S, Yajima M, Gelman AE, Hill J (2011) Multiple imputation with diagnostics (mi) in R: Opening windows into the black box. J Stat Softw 45(2):1–31CrossRef Su Y-S, Yajima M, Gelman AE, Hill J (2011) Multiple imputation with diagnostics (mi) in R: Opening windows into the black box. J Stat Softw 45(2):1–31CrossRef
27.
28.
go back to reference Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16(4):385–395CrossRefPubMed Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16(4):385–395CrossRefPubMed
29.
go back to reference Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley series in probability and mathematical statistics applied probability and statistics. Wiley, New York Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley series in probability and mathematical statistics applied probability and statistics. Wiley, New York
30.
go back to reference Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN (2014) Gene panel testing for inherited cancer risk. J Natl Compr Canc Netw 12(9):1339–1346PubMed Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN (2014) Gene panel testing for inherited cancer risk. J Natl Compr Canc Netw 12(9):1339–1346PubMed
31.
go back to reference Hamann HA, Tiro JA, Sanders JM, Melhado TV, Funk RK, Carpentier MY, Bartholomew LK, Argenbright KE, Vernon SW (2013) Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors. J Cancer Surviv 7(4):624–629. doi:10.1007/s11764-013-0301-y CrossRefPubMed Hamann HA, Tiro JA, Sanders JM, Melhado TV, Funk RK, Carpentier MY, Bartholomew LK, Argenbright KE, Vernon SW (2013) Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors. J Cancer Surviv 7(4):624–629. doi:10.​1007/​s11764-013-0301-y CrossRefPubMed
33.
go back to reference Khoury MJ, Bowen S, Bradley LA, Coates R, Dowling NF, Gwinn M, Kolor K, Moore CA, St Pierre J, Valdez R, Yoon PW (2009) A decade of public health genomics in the United States: centers for disease control and prevention 1997–2007. Public Health Genom 12(1):20–29. doi:10.1159/000153427 CrossRef Khoury MJ, Bowen S, Bradley LA, Coates R, Dowling NF, Gwinn M, Kolor K, Moore CA, St Pierre J, Valdez R, Yoon PW (2009) A decade of public health genomics in the United States: centers for disease control and prevention 1997–2007. Public Health Genom 12(1):20–29. doi:10.​1159/​000153427 CrossRef
34.
go back to reference Syurina EV, Brankovic I, Probst-Hensch N, Brand A (2011) Genome-based health literacy: a new challenge for public health genomics. Public Health Genom 14(4–5):201–210. doi:10.1159/000324238 CrossRef Syurina EV, Brankovic I, Probst-Hensch N, Brand A (2011) Genome-based health literacy: a new challenge for public health genomics. Public Health Genom 14(4–5):201–210. doi:10.​1159/​000324238 CrossRef
35.
go back to reference Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Knoppers BM, Khoury MJ, Meslin EM, Van Duijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W (2014) Beyond public health genomics: proposals from an international working group. Eur J Public Health 24(6):877–879. doi:10.1093/eurpub/cku142 CrossRefPubMed Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Knoppers BM, Khoury MJ, Meslin EM, Van Duijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W (2014) Beyond public health genomics: proposals from an international working group. Eur J Public Health 24(6):877–879. doi:10.​1093/​eurpub/​cku142 CrossRefPubMed
36.
go back to reference Modell SM, Greendale K, Citrin T, Kardia SL Expert and advocacy group consensus findings on the horizon of public health genetic testing. In: Healthcare, 2016. vol 1. Multidisciplinary Digital Publishing Institute, p 14 Modell SM, Greendale K, Citrin T, Kardia SL Expert and advocacy group consensus findings on the horizon of public health genetic testing. In: Healthcare, 2016. vol 1. Multidisciplinary Digital Publishing Institute, p 14
Metadata
Title
Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study
Authors
Maria C. Katapodi
Deb Duquette
James J. Yang
Kari Mendelsohn-Victor
Beth Anderson
Christos Nikolaidis
Emily Mancewicz
Laurel L. Northouse
Sonia Duffy
David Ronis
Kara J. Milliron
Nicole Probst-Herbst
Sofia D. Merajver
Nancy K. Janz
Glenn Copeland
Scott Roberts
Publication date
01-03-2017
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2017
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0858-2

Other articles of this Issue 3/2017

Cancer Causes & Control 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine